Norihiro Matsuura
Papers
3
Total Citations
25
H-Index
2
About
Norihiro Matsuura is a leading surgical oncologist whose work centers on advanced gastric and gastroesophageal junction cancers, with a particular focus on novel targeted therapies and minimally invasive surgical techniques. His major contributions include pioneering real-world evidence on the adverse effects of zolbetuximab—a CLDN18.2-targeting antibody—demonstrating its efficacy in HER2-negative patients while documenting rare complications like protein-losing enteropathy (13 citations). He has also advanced the field of conversion surgery, showing that zolbetuximab-based chemotherapy can enable successful resection in previously inoperable CLDN18.2-positive tumors. In comparative surgical outcomes, Matsuura’s research on robotic versus laparoscopic gastrectomy (10 citations) provides critical perioperative and three-year survival data, helping refine treatment algorithms. His work bridges the gap between clinical trials and real-world practice, offering actionable insights for managing complex gastric cancer cases. With a growing citation impact and a focus on translating molecular targets into surgical strategies, Matsuura is shaping the next generation of multimodal, precision-driven gastric cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3